Analysis of HLA class I specific antibodies in patients with failed allografts

被引:36
作者
Mao, Quanzong
Terasaki, Paul I.
Cai, Junchao
El-Awar, Nadim
Rebellato, Lorita
机构
[1] Terasaki Fdn Lab, Los Angeles, CA USA
[2] One Lambda Inc, Los Angeles, CA USA
[3] E Carolina Univ, Brody Sch Med, Dept Pathol, Greenville, NC USA
关键词
HLA antibody; epitope; graft failure; kidney transplant; donor specific antibody;
D O I
10.1097/01.tp.0000250492.55775.83
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. The goals of this study are first to determine the epitope specificity of donor specific antibody (DSA) in the serum of alloimmunized transplant patients with a failed renal graft; and second to understand the correlation between the development of DSA and nondonor specific antibody (NDSA). Methods. The sera of 35 pretransplant panel reactive antibody (PRA)-negative patients with failed allografts were examined with single-antigen (SA) luminex beads to identify human leukocyte antigen (HLA)-A and -B antibodies. Potential HLA antibody epitopes were identified by using computer software and verified by absorption and elution from single-antigen cell lines. Results. Twenty-seven patients developed donor-specific HLA-A and/or -B antibodies, while the remaining eight patients had only nonclonor-specific HLA-A and/or -B antibodies. The DSA-positive patients also had a long list of NDSA. Sixty-eight percent of the reactions found in 27 recipients with DSA were attributable to 66 epitopes on the mismatched donor HLA molecule. All 39 NDSA in eight patients with only NDSA shared 17 epitopes within positive allele specificities. By absorption and elution using recombinant cell lines having a single HLA specificity, we confirmed the epitopes involved in three patients. Conclusion. Development of most NDSA in patients with failed allografts is likely due to sharing epitopes with DSA and/or other NDSA.
引用
收藏
页码:54 / 61
页数:8
相关论文
共 13 条
[1]   Serum analysis after transplant nephrectomy reveals restricted antibody specificity patterns against structurally defined HLA class I mismatches [J].
Adeyi, OA ;
Girnita, AL ;
Howe, J ;
Marrari, M ;
Awadalla, Y ;
Askar, M ;
Martell, J ;
Zeevi, A ;
Shapiro, R ;
Nalesnik, M ;
Randhawa, P ;
Demetris, AJ ;
Duquesnoy, RJ .
TRANSPLANT IMMUNOLOGY, 2005, 14 (01) :53-62
[2]   Development of nondonor-specific HLA-DR antibodies in allograft recipients is associated with shared epitopes with mismatched donor DR antigens [J].
Cai, J. ;
Terasaki, P. I. ;
Mao, Q. ;
Pham, T. ;
El-Awar, N. ;
Lee, J. -H. ;
Rebellato, L. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2006, 6 (12) :2947-2954
[3]   Humoral theory of transplantation: Mechanism, prevention, and treatment [J].
Cai, J ;
Terasaki, PI .
HUMAN IMMUNOLOGY, 2005, 66 (04) :334-342
[4]   Correlation between human leukocyte antigen antibody production and serum creatinine in patients receiving sirolimus monotherapy after Campath-1H induction [J].
Cai, JC ;
Terasaki, PI ;
Bloom, DD ;
Torrealba, JR ;
Friedl, A ;
Sollinger, HW ;
Knechtle, SJ .
TRANSPLANTATION, 2004, 78 (06) :919-924
[5]   HLA antibody identification with single antigen beads compared to conventional methods [J].
El-Awar, N ;
Lee, J ;
Terasaki, PI .
HUMAN IMMUNOLOGY, 2005, 66 (09) :989-997
[6]   Almost all patients who are waiting for a regraft of a kidney transplant have anti-HLA antibodies [J].
El-Awar, N ;
Terasaki, P ;
Lazda, V ;
Nikaein, A ;
Manning, C ;
Arnold, AN .
TRANSPLANTATION PROCEEDINGS, 2002, 34 (07) :2531-2532
[7]  
ELAWAR N, IN PRESS HUMAN IMMUN
[8]   Frequency and clinical implications of development of donor-specific and non-donor-specific HLA antibodies after kidney transplantation [J].
Hourmant, M ;
Cesbron-Gautier, A ;
Terasaki, PI ;
Mizutani, K ;
Moreau, A ;
Meurette, A ;
Dantal, J ;
Giral, M ;
Blancho, G ;
Cantarovich, D ;
Karam, G ;
Follea, G ;
Soulillou, JP ;
Bignon, JD .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (09) :2804-2812
[9]   Detection of donor-specific anti-HLA antibodies with flow cytometry in eluates and sera from renal transplant recipients with chronic allograft nephropathy [J].
Martin, L ;
Guignier, F ;
Mousson, C ;
Rageot, D ;
Justrabo, E ;
Rifle, G .
TRANSPLANTATION, 2003, 76 (02) :395-400
[10]   Serial ten-year follow-up of HLA and MICA antibody production prior to kidney graft failure [J].
Mizutani, K ;
Terasaki, P ;
Rosen, A ;
Esquenazi, V ;
Miller, J ;
Shih, RNJ ;
Pei, R ;
Ozawa, M ;
Lee, J .
AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 (09) :2265-2272